GangaGen is a biotech company that’s working on bacteriophages, which are viruses that infect and destroy bacteria. The company raised $1.8 million to develop treatments for antibiotic-resistant bacterial infections like pneumonia and MRSA, a skin infection that plagues hospitals.
This is the San Francisco, Calif. company’s first funding round. ATEL Ventures made the investment.
Next Story: Industrial Origami funded with $17M for metal-folding magic
Previous Story: Location comes to the web browser with Mozilla's Geode
Tags: deal
